Adverse events with regional citrate anticoagulation versus heparin anticoagulation during continuous renal replacement therapy: a systematic review and trial sequential analysis

Min-min Wang, Marshall Mark, Wen-yan Yu, Qiang Yao

Open source

DOI
10.3969/j.issn.1671-2390.2023.10.006
Published
10
Container
Linchuang shenzangbing zazhi
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3969/j.issn.1671-2390.2023.10.006,
  title = {Adverse events with regional citrate anticoagulation versus heparin anticoagulation during continuous renal replacement therapy: a systematic review and trial sequential analysis},
  author = {Min-min Wang and Marshall Mark and Wen-yan Yu and Qiang Yao},
  year = {2023},
  journal = {Linchuang shenzangbing zazhi},
  doi = {10.3969/j.issn.1671-2390.2023.10.006},
  url = {https://doi.org/10.3969/j.issn.1671-2390.2023.10.006}
}

RIS

TY  - JOUR
TI  - Adverse events with regional citrate anticoagulation versus heparin anticoagulation during continuous renal replacement therapy: a systematic review and trial sequential analysis
AU  - Min-min Wang
AU  - Marshall Mark
AU  - Wen-yan Yu
AU  - Qiang Yao
PY  - 2023
JO  - Linchuang shenzangbing zazhi
DO  - 10.3969/j.issn.1671-2390.2023.10.006
UR  - https://doi.org/10.3969/j.issn.1671-2390.2023.10.006
ER  - 

APA

Wang, M., Mark, M., Yu, W., & Yao, Q. (2023). Adverse events with regional citrate anticoagulation versus heparin anticoagulation during continuous renal replacement therapy: a systematic review and trial sequential analysis. Linchuang shenzangbing zazhi. https://doi.org/10.3969/j.issn.1671-2390.2023.10.006

Source records